Sort by Expiration Date:
Filter:

Online Programs

Sort by Expiration Date:
Filter:

Moderate-to-Severe Atopic Dermatitis: Improving Patient Adherence to Therapy Among Veterans During the COVID-19 Pandemic

This enduring education is designed to help dermatologists, allergists, immunologists, primary care physicians, and other health care professionals in the Department of Veterans Affairs to identify the signs and symptoms of atopic dermatitis in adult patients, assess disease severity, incorporate updated guidance on the use of systemic therapy for atopic dermatitis during the COVID-19 pandemic into clinical practice, and utilize shared decision making to help individualize care.

Release Date: August 26, 2021
Expiration Date: August 26, 2022

Learn More & View Event »

Seeing Past the Treatment Horizon: Anti-VEGF Therapies and Beyond in Retinal Disease (Diabetic Retinopathy)

This online activity targets healthcare gaps related to evidence-based recognition and prevention as well as timely treatment and management of diabetic retinopathy (DR), impacting visual outcomes through guidelines and best practices, clinical trial data and strategies to facilitate earlier initiation of therapy.

Release Date: September 17, 2021
Expiration Date: September 17, 2022

Learn More & View Event »

Seeing Past the Treatment Horizon: Anti-VEGF Therapies and Beyond in Retinal Disease (Optometry)

This online activity targets healthcare gaps related to evidence-based recognition and prevention as well as timely treatment and management of diabetic retinopathy (DR), impacting visual outcomes through guidelines and best practices, clinical trial data and strategies to facilitate earlier initiation of therapy.

Release Date: September 17, 2021
Expiration Date: September 17, 2022

Learn More & View Event »

The Virtual Reality Room Seeing Past the Treatment Horizon: Anti-VEGF Therapies and Beyond in Retinal Disease Track: Age-related Macular Degeneration (Optometry)

This online activity targets healthcare gaps related to evidence-based recognition and prevention as well as timely treatment and management of age-related macular degeneration (AMD), impacting visual outcomes through guidelines and best practices, clinical trial data and strategies to facilitate earlier initiation of therapy.
RELEASE DATE: October 01, 2021

EXPIRATION DATE: October 01, 2022

Learn More & View Event »

The Virtual Reality Room Seeing Past the Treatment Horizon: Anti-VEGF Therapies and Beyond in Retinal Disease Track: Age-related Macular Degeneration (Retina)

This online activity targets healthcare gaps related to evidence-based recognition and prevention as well as timely treatment and management of age-related macular degeneration (AMD), impacting visual outcomes through guidelines and best practices, clinical trial data and strategies to facilitate earlier initiation of therapy.
RELEASE DATE: October 01, 2021

EXPIRATION DATE: October 01, 2022

Learn More & View Event »

Seeing New Possibilities in Retinal Disease: Anti-VEGF Therapies and Beyond

This online activity targets healthcare gaps related to the recognition, prevention, and management of diabetic retinopathy (DR). An expert panel discussion will guide you in identifying candidates for anti-VEGF therapy, review clinical trial data on the use of these agents, and provide evidence-based strategies to individualize the management of DR and overcome treatment barriers.

RELEASE DATE: October 01, 2021

EXPIRATION DATE: October 01, 2022

Learn More & View Event »

Maximizing Personalized Approaches Through Composite Biomarkers in Metastatic NSCLC: An Innovative 2D View

This activity consists of presentations from expert faculty and 2D animation technology to explain immune dysfunction and the pathogenesis of non-small cell lung cancer (NSCLC), currently available and emerging immuno-oncology used alone and in combination with chemotherapy for NSCLC, and the usefulness and application of biomarkers to guide treatment selection for NSCLC.
RELEASE DATE: October 06, 2021

EXPIRATION DATE: October 06, 2022

Learn More & View Event »

Personalizing Treatment for Parkinson’s Disease: What Can You Do to Manage Off Episodes in Your Patients?

This program will explore the management of “off” episodes in patients with Parkinson’s disease. Interactive case studies presented by expert faculty will evaluate pharmacologic approaches to reduce daily off time, including the efficacy and safety of on-demand therapies. Engaging whiteboard animation will review the pathophysiology of off episodes and the mechanism of action of treatment options.
RELEASE DATE: October 08, 2021

EXPIRATION DATE: October 08, 2022

Learn More & View Event »

Personalizing Treatment for Parkinson’s Disease: What Can You Do to Manage Off Episodes in Your Patients?

This program will explore the management of off episodes in patients with Parkinson’s disease. Interactive case studies presented by ex pert faculty will evaluate pharmacologic approaches to reduce daily off time, including the efficacy and safety of on-demand therapies. Engaging whiteboard animation will review the pathophysiology of off episodes and the mechanism of action of treatment options.
RELEASE DATE: October 21, 2021

EXPIRATION DATE: October 21, 2022

Learn More & View Event »

Seeing Past the Treatment Horizon: Anti-VEGF Therapies and Beyond in Retinal Disease Track: Retinal Vein Occlusion

This online activity targets healthcare gaps related to evidence-based recognition and prevention as well as timely treatment and management of retinal vein occlusion (RVO), impacting visual outcomes through guidelines and best practices, clinical trial data and strategies to facilitate earlier initiation of therapy.
RELEASE DATE: October 29, 2021

EXPIRATION DATE: October 29, 2022

Learn More & View Event »

Seeing Past the Treatment Horizon: Anti-VEGF Therapies and Beyond in Retinal Disease Track: Retinal Vein Occlusion

This online activity targets healthcare gaps related to evidence-based recognition and prevention as well as timely treatment and management of retinal vein occlusion (RVO), impacting visual outcomes through guidelines and best practices, clinical trial data and strategies to facilitate earlier initiation of therapy.
RELEASE DATE: October 29, 2021

EXPIRATION DATE: October 29, 2022

Learn More & View Event »

What Can You Do to Improve Clinical Outcomes for Your Patients with Viral Influenza at High-Risk for Pulmonary Complications?

This virtual satellite symposium discusses best practices for managing people with influenza who are at high risk for developing pulmonary complications. 2D animation technology is incorporated throughout the program to highlight the mechanism of action of point-of-care tests (POCTs) and antiviral treatments approved for treatment. Clinical data supporting the efficacy of antivirals and guidance on their use will also be provided.

RELEASE DATE: November 19, 2021

EXPIRATION DATE: November 19, 2022

Learn More & View Event »

Parkinson’s Disease Psychosis is Often Underdiagnosed and Undertreated: What Can You Do to Improve the Quality of Care for Your Patients?

In this virtual program, we will explore the management of Parkinson’s disease psychosis (PDP)–a condition that affects a substantial percentage of patients with Parkinson’s disease, typically in the later stages. Through this interactive program, clinicians will recognize symptoms, features, and diagnostic best practices in PDP. In addition, participants will learn about the underlying pathophysiology of PDP and treatments targeting these underlying pathways pivotal to the progression of PDP. Through an improved understanding of PDP, clinicians will gain insights and tools to better manage patients with PDP. Through interactive case studies presented by expert faculty, learners will be able to better evaluate pharmacologic approaches to PDP management and the efficacy and safety of approved therapeutic options. In addition, engaging whiteboard animations presented throughout will reinforce concepts learned in didactic portion, ensuring that participants understand the pathophysiology and mechanisms involved in pharmacologic management of PDP.

RELEASE DATE: November 26, 2021

EXPIRATION DATE: November 26, 2022

Learn More & View Event »

Atopic Dermatitis: Targeting Underlying Inflammatory Pathways with Systemic Therapy – THE THRIVE INITIATIVE

Upon the completion of this program, attendees should be able to:

  • Apply up-to-date guidance on the initiation and use of systemic immunosuppressants and immunomodulators in patients with atopic dermatitis during the COVID-19 pandemic
  • Assess the severity of atopic dermatitis and select appropriate treatment options for patients who require intensified therapy
  • Review the mechanism of action, efficacy and safety of systemic treatments for atopic dermatitis in pediatric and adult patients

RELEASE DATE: December 01, 2021

EXPIRATION DATE: December 01, 2022

Learn More & View Event »

Moderate-to-Severe Asthma: Targeting Underlying Inflammatory Processes to Improve Patient Outcomes

This enduring program consists of presentations from expert faculty and simulation challenge animations that will explain immune dysfunction and the pathogenesis of moderate-to-severe asthma, currently available and emerging targeted therapies used for asthma, and the usefulness and application of guidelines and biomarkers to guide treatment selection for this disease.

RELEASE DATE: December 07, 2021

EXPIRATION DATE: December 07, 2022

Learn More & View Event »

Leveraging Novel Treatment Options for Small-Cell Lung Cancer in the Second Line

This enduring virtual TeleECHO program will explore the management of small cell lung cancer (SCLC) in the second-line setting. A brief didactic presentation will discuss treatment options after relapse of SCLC and will assess clinical trial data regarding the efficacy and safety of second-line treatment regimens. Interactive case studies will illustrate the application of guideline recommendations for treatments approved for managing extensive-stage SCLC.

RELEASE DATE: December 07, 2021

EXPIRATION DATE: December 07, 2022

Learn More & View Event »

Parkinson’s Disease Psychosis is Often Underdiagnosed and Undertreated: What Can You Do to Improve the Quality of Care for Your Patients?

In this virtual program, we will explore the management of Parkinson’s disease psychosis (PDP)–a condition that affects a substantial percentage of patients with Parkinson’s disease, typically in the later stages. Through this interactive program, clinicians will recognize symptoms, features, and diagnostic best practices in PDP. In addition, participants will learn about the underlying pathophysiology of PDP and treatments targeting these underlying pathways pivotal to the progression of PDP. Through an improved understanding of PDP, clinicians will gain insights and tools to better manage patients with PDP. Through interactive case studies presented by expert faculty, learners will be able to better evaluate pharmacologic approaches to PDP management and the efficacy and safety of approved therapeutic options. In addition, engaging whiteboard animations presented throughout will reinforce concepts learned in didactic portion, ensuring that participants understand the pathophysiology and mechanisms involved in pharmacologic management of PDP.

RELEASE DATE: December 21, 2021

EXPIRATION DATE: December 21, 2022

Learn More & View Event »

Advances in the Therapeutic Management of Patients with Chronic Hematological Conditions – A Whiteboard Preceptorship

Recent advances in treatment strategies promise to improve the lives of patients with sickle cell disease or hemophilia. In this program, experts in both fields will assist clinicians in developing individualized management plans using state-of-the-art and emerging therapies, and highlight opportunities to implement multidisciplinary, patient-centered approaches to care. Case studies and interactive question and answers will provide learners practice in applying patient-specific factors to treatment decisions. This activity will feature whiteboard animations that will reinforce learning and help participants gain a higher level of understanding.

RELEASE DATE: December 21, 2021

EXPIRATION DATE: December 21, 2022

Learn More & View Event »

Understanding Cervical Biology and Oncogenesis: Leveraging Checkpoint Inhibition in Recurrent and Metastatic Disease

This case-based online activity will help gynecologists and medical oncologists improve the timeliness of screening for women at risk for cervical cancer and the accuracy of diagnosis; and recognize the limitations of currently available regimens for recurrent and metastatic disease. The education will also seek to expand awareness of the integral role that the immune system plays in the pathology of cervical cancer and how IO agents in late-stage development for patients with recurrent or metastatic cervical cancer potentially could be integrated into practice once available.

RELEASE DATE: December 23, 2021

EXPIRATION DATE: December 23, 2022

Learn More & View Event »

A Holistic Approach to Diabetes Care: Reducing HbA1c and Weight with Emerging Pharmacotherapies

  • Select therapies for the improvement of glycemic and extra-glycemic outcomes in patients with T2DM.
  • Determine the rationale for targeting GIP and GLP-1 receptors in the treatment of type2 diabetes and its metabolic comorbidities.
  • Identify patients in their own practice who may potentially benefit from treatments targeting GIP and GLP-1 receptors in the future based on knowledge of recent clinical data

RELEASE DATE: December 28, 2021

EXPIRATION DATE: December 28, 2022

Learn More & View Event »

A Holistic Approach to Diabetes Care: Reducing HbA1c and Weight with Emerging Pharmacotherapies

This activity will explore strategies to improve glycemic and metabolic outcomes in patients with type 2 diabetes mellitus (T2DM). A review of clinical trial data will enable clinicians to personalize the selection of therapies for patients and examine the role of emerging dual GIP and GLP-1 receptor agonists in the management of type 2 diabetes and obesity.

RELEASE DATE: December 29, 2021

EXPIRATION DATE: December 29, 2022

Learn More & View Event »

Clinical Conversations Exchange: A Cardiologist-PCP Collaboration Discussing GLP-1 Receptor Agonists for Reducing Cardiovascular Risk in Patients with Diabetes

  • Determine the clinical implications of results from Cardiovascular Outcomes Trials of GLP-1 receptor agonists
  • Identify patients with type 2 diabetes who are most likely to benefit from the use of GLP-1 receptor agonists
  • Personalize the selection of GLP-1 receptor agonists based on indications, guidelines recommendations and clinical data
  • Develop strategies for increasing collaboration between cardiologists and PCPs in managing cardiovascular risk in patients with T2DM

RELEASE DATE: January 27, 2022

EXPIRATION DATE: January 27, 2023

Learn More & View Event »

Advances in the Management of Prurigo Nodularis: Stopping the Itch-Scratch Cycle

  • Develop treatment regimens that address the immunological and neural components of prurigo nodularis (PN)
  • Integrate patient-specific factors, such as quality of life and comorbidities, into the selection of treatment options for the management of PN
  • Assess clinical trial data on the efficacy and safety of emerging therapies for the treatment of PN

RELEASE DATE: January 31, 2022

EXPIRATION DATE: January 31, 2023

Learn More & View Event »

Going Beyond the Classic Management of Cutaneous Squamous Cell Carcinoma: Anti-PD1 Therapy

  • Discuss the elements of immune dysfunction that drive the tumorigenesis of cutaneous squamous cell carcinoma (cSCC)
  • Review risk stratification of patients with cutaneous squamous cell carcinoma to determine who are at high risk of recurrence
  • Describe the application of medical practice guidelines and supporting trial data to the treatment of patients with locally advanced and metastatic cSCC

RELEASE DATE: February 10, 2022

EXPIRATION DATE: February 10, 2023

Learn More & View Event »

Prurigo Nodularis: Therapeutic Possibilities

  • Develop treatment regimens that address the immunological and neural components of prurigo nodularis (PN)
  • Integrate patient-specific factors, such as quality of life and comorbidities, into the selection of treatment options for the management of PN
  • Assess clinical trial data on the efficacy and safety of emerging therapies for the treatment of PN

RELEASE DATE: February 16, 2022

EXPIRATION DATE: February 16, 2023

Learn More & View Event »

New Optimal Low-density Lipoprotein Cholesterol Reductions in Patients with Atherosclerotic Cardiovascular Disease: Maximizing Clinical Benefit within the Department of Veterans Affairs

This activity is designed to help lipidologists, cardiologists, and other healthcare professionals involved in the management of US veterans with familial hypercholesterolemia (FH) to improve cholesterol and cardiovascular outcomes for veteran patients.

RELEASE DATE: February 23, 2022

EXPIRATION DATE: February 23, 2023

Learn More & View Event »

Assessing Severity of Alopecia Areata and Understanding the Role of Novel Systemic Therapies

This activity provides a practice-based learning experience for dermatologist and primary care physicians regarding the assessment and treatment of alopecia areata (AA). By participating in this Simulation Center, learners will observe an interaction between a physician and their patient with AA and will test their knowledge of diagnosis and management at key decision points along the way. The burden of AA and its associated comorbidities will be highlighted, and you will learn strategies to effectively address the psychosocial impacts of this disease with your patients.

RELEASE DATE: February 23, 2022

EXPIRATION DATE: February 23, 2023

Learn More & View Event »

Assessing the Growing Evidence in Alopecia Areata: The Role of JAK Inhibitors

This enduring activity discusses the underlying autoimmune causes of alopecia areata (AA) and the rationale of targeted treatment approaches. The burden of AA and its associated comorbidities will also be presented, and you will hear strategies to effectively address the psychosocial impacts of this disease with your patients. Features of this program include whiteboard animations and case studies.

RELEASE DATE: February 25, 2022

EXPIRATION DATE: February 25, 2023

Learn More & View Event »

Improving SMBG Skills – The Power is in Their Hands: The Role of Diabetes Self-Management Education and Support in Patients Receiving Insulin

This activity will help participants to overcome clinical inertia and other potential barriers to timely and appropriate insulin therapy in patients with type 2 diabetes. Participants will be equipped with an enhanced ability to select, titrate and adjust basal insulin regimens, and to successfully educate and empower their patients to self-manage their diabetes.

RELEASE DATE: February 25, 2022

EXPIRATION DATE: February 25, 2023

Learn More & View Event »

Managing the Older Adult with T2DM: The Role of Fixed-Ratio GLP-1 Receptor Agonist/Insulin Combinations

This CME activity will help participants identify the characteristics of older adults with type 2 diabetes that require special consideration, assess older patients with type 2 diabetes, and develop personalized pharmacotherapeutic strategies for older patients with type 2 diabetes, both in the community and in long-term care, that include the use of fixed-ratio GLP-1 receptor agonist/insulin combinations. The activity features a Situation Room, a unique online program which employs a patient simulation platform. The situation room provides interactive quizzing, testing, and training via immersion-focused 3D simulations of scenarios encountered by clinicians who care for older adults with type 2 diabetes. The experience will be customized based on who is using the simulation. One track will be aimed at geriatricians and endocrinologists, and the other will be aimed at PCPs, physician extenders and consultant pharmacists. A slide presentation will guide the learners in their selection of treatment strategies.

RELEASE DATE: February 25, 2022

EXPIRATION DATE: February 25, 2023

Learn More & View Event »

New Treatments Bring New Challenges: Can You Identify and Mitigate Therapy-related Adverse Events Associated with the Use of Immuno-oncology/Tyrosine Kinase Inhibitor Combination Therapies?

  • Interpret data from studies exploring the safety/toxicity profiles of IO/TKI combination therapies used to treat patients with advanced solid tumors
  • Develop strategies to manage the irAEs and trAEs associated IO/TKI combination therapies used for the treatment of patients with advanced solid tumors
  • Support multidisciplinary team approaches for the diagnosis and management of irAEs in patients with advanced solid tumors treated with combination IO/TKI therapies

RELEASE DATE: February 28, 2022

EXPIRATION DATE: February 28, 2023

Learn More & View Event »

Assessing the Growing Evidence in Alopecia Areata: The Role of JAK Inhibitors

This enduring activity will discuss the causes of alopecia areata and how to best manage this disease. Expert faculty will highlight the burden of alopecia areata and will offer participants strategies for implementing treatment plans that will not only address the disease itself, but also the overall health challenges for this patient population.

RELEASE DATE: March 02, 2022

EXPIRATION DATE: March 02, 2023

Learn More & View Event »

The CATALYST Initiative: Expanding Knowledge to Improve Clinical Decision-Making and Health Outcomes for Patients with Hematologic Malignancies: A Focus on CLL

This case-based enduring activity is designed to help community oncologists and the multidisciplinary care team choose the optimal treatment for chronic lymphocytic leukemia (CLL) based on patient and disease characteristics, including performance status, organ function, comorbidities, drug interactions, and genetic and molecular biomarkers; monitor for and manage adverse events; and implement SDM into clinical practice to improve patient care and QoL.

RELEASE DATE: March 04, 2022

EXPIRATION DATE: March 04, 2023

Learn More & View Event »

Immuno-oncology Therapies for the Treatment of Advanced Endometrial Cancer: Which of Your Patients May Benefit from Their Use?

This enduring TeleECHO program will explore the management of patients with advanced endometrial cancer through interactive case studies. Faculty will review strategies on personalizing the selection of treatment options based on molecular testing and discuss the management of adverse events with immune-oncology/tyrosine kinase inhibitor combination therapies.

RELEASE DATE: March 04, 2022

EXPIRATION DATE: March 04, 2023

Learn More & View Event »

Assessing the Growing Evidence in Alopecia Areata:
The Role of JAK Inhibitors

This enduring activity discusses the underlying autoimmune causes of alopecia areata (AA) and the rationale of targeted treatment approaches. The burden of AA and its associated comorbidities will also be presented, and you will hear strategies to effectively address the psychosocial impacts of this disease with your patients. Features of this program include whiteboard animations, case presentations, and a pre-recorded Q&A session.

RELEASE DATE: March 09, 2022

EXPIRATION DATE: March 09, 2023

Learn More & View Event »

Atopic Dermatitis: Managing the Burden of Moderate-to-Severe Disease and Its Associated Comorbidities

This activity will explore the management of pediatric and adult patients with moderate-to-severe atopic dermatitis through interactive case-based simulations. Expert faculty will review strategies on how to personalize the selection of systemic treatment options based on guideline recommendations, evidence-based best practice, and emerging clinical trial data. Case-based simulations will help learners identify candidates for systemic therapy and address safety and quality of life issues.

RELEASE DATE: March 11, 2022

EXPIRATION DATE: March 11, 2023

Learn More & View Event »

Exploring Chronic Rhinosinusitis With Nasal Polyps (CRSwNP): Diagnostic Best Practices and Considerations in Addressing Underlying Inflammation

This enduring program is designed for allergists, otolaryngologists, primary care clinicians, and other clinical team members who manage chronic rhinosinusitis with nasal polyps. In this program, we will aim to discuss the burden and pathophysiology of CRSwNP, review guidelines for diagnosis and short- and long-term management, look at clinical data and biomarkers on current and novel anti-inflammatory biologics, and teach clinicians how to apply best practices for the interdisciplinary development of individualized treatment plans for these patients. We will use a combination of didactic lecture, video animations, and patient cases to effectively teach clinicians who manage this condition.

RELEASE DATE: March 11, 2022

EXPIRATION DATE: March 11, 2023

Learn More & View Event »

Optimizing the Care of Patients with Moderate-to-Severe Asthma: Minimizing Asthma Exacerbations with Biologic Therapy

This enduring program consists of presentations from expert faculty and simulation challenge animations that will explain immune dysfunction and the pathogenesis of moderate-to-severe asthma, currently available and emerging targeted therapies used for asthma, and the usefulness and application of guidelines and biomarkers to guide treatment selection for this disease.

RELEASE DATE: March 11, 2022

EXPIRATION DATE: March 11, 2023

Learn More & View Event »

Expert Perspectives on Managing Moderate-to-Severe Atopic Dermatitis in Pediatric and Adult Patients

This enduring virtual activity targets healthcare gaps related to the diagnosis, treatment, and individualized management of AD, impacting outcomes through identifying burdens affecting quality of life, assessing disease severity when considering topical vs systemic intervention, and utilizing strategies in shared decision-making when determining guideline-based care.

RELEASE DATE: March 28, 2022

EXPIRATION DATE: March 28, 2023

Learn More & View Event »

Evaluating and Managing Ocular Toxicities and Other Potential Adverse Events in the Management of Relapsed/Refractory Multiple Myeloma

This enduring TeleECHO program will explore the management of ocular toxicities and other adverse events related to treatment of relapsed and refractory multiple myeloma (RRMM). A brief didactic presentation will discuss how and why these adverse events occur. The importance of Risk Evaluation and Mitigation Strategy (REMS) programs for monitoring your patients for corneal changes and other effects of later-line therapy for multiple myeloma will also be presented. Interactive case studies will illustrate strategies for choosing therapy and for managing treatment-related adverse events in the RRMM setting.

RELEASE DATE: March 28, 2022

EXPIRATION DATE: March 28, 2023

Learn More & View Event »

Advances in the Treatment of Patients with Systemic Lupus Erythematosus: Leveraging its Pathogenic Pathways to Improve Outcomes

  • Describe the immune cells and proinflammatory proteins that represent therapeutic targets in SLE including BAFF, type 1 interferon, and cytokines associated with JAK/STAT signaling
  • Explain how dysregulated innate and adaptive immune responses lead to specific clinical manifestations and disease consequences in patients with SLE
  • Evaluate the safety and efficacy of new and emerging SLE therapies that target its pathogenetic pathways
  • Select treatments for patients with SLE based on their pathogenic rationale

RELEASE DATE: March 30, 2022
EXPIRATION DATE: March 30, 2023

Learn More & View Event »

Putting Novel Antibody Therapies for COVID-19 in Clinical Context: Evaluating Clinical Data, Monitoring, Infusion Best Practices, and Pediatric EUAs

COVID-19 FRONTLINE podcasts provide an up-to-date perspective on the use of monoclonal antibodies for the treatment and prevention of COVID-19. Each podcast focuses on different issues facing clinicians, such as identifying candidates for monoclonal antibody therapy, improving access to therapies, incorporating best practices into clinical care, and other important topics.

RELEASE DATE: March 30, 2022

EXPIRATION DATE: March 30, 2023

Learn More & View Event »

Opportunities for Nephrology Fellows to Innovate on CKD risk in Patients With T2D: Novel Developments in Mineralocorticoid Antagonists

The online activity will address renoprotective therapies in care of patients with T2D and CKD with a focus on mineralocorticoid receptor antagonists and SGLT2 inhibitors. Discussion will include mechanisms of action, emerging clinical data, best practices in screening patients, and management considerations for hyperkalemia.

RELEASE DATE: March 30, 2022

EXPIRATION DATE: March 30, 2023

Learn More & View Event »

Disease Modification in Individuals with Moderate-to-Severe Rheumatoid Arthritis: Optimizing Treatment Through the Finely Tuned Selectivity for JAKs

This enduring TeleECHO activity will explore the use of JAK inhibitors for the management of rheumatoid arthritis (RA) through interactive case studies. Faculty will review emerging efficacy and safety data, discuss guideline recommended care of RA, and help clinicians identify candidates for treatment with JAK inhibitors.

RELEASE DATE: April 04, 2022
EXPIRATION DATE: April 04, 2023

Learn More & View Event »

Therapeutic Options in Hepatorenal Syndrome with Acute Kidney Injury: Confirming the Value of Systemic Vasoconstriction

This enduring activity targets healthcare gaps related to the diagnosis, treatment, and individualized management of hepatorenal syndrome with acute kidney injury (HRS-AKI), impacting outcomes through diagnosis and differentiation from other forms of AKI as well as individualizing pharmacotherapeutic management.

  • By addressing these gaps, you can assess whether your approach to HRS-AKI diagnosis and management through utilization of the latest clinical trial data on emerging pharmacotherapies – could be modified to help close these gaps.
  • Expert discussion will guide you in analyzing and identifying challenges to HRS-AKI diagnosis and staging, the evolution of pharmacotherapies in HRS-AKI, and relevant clinical considerations to their application in case management.
  • You will also be immersed in interactive, animated simulation case studies to memorably highlight key points related to assessment and treatment options in HRS-AKI.

RELEASE DATE: April 05, 2022
EXPIRATION DATE: April 05, 2023

Learn More & View Event »

Putting Novel Antibody Therapies for COVID-19 in Clinical Context: Evaluating Clinical Data, Monitoring, Infusion Best Practices, and Pediatric EUAs

This educational activity will explore the use of monoclonal antibodies for the treatment and prevention of COVID-19 in pediatric patients. A review of available clinical data will help clinicians identify candidates for therapy and select appropriate treatments based on the most up-to-date information.

RELEASE DATE: April 08, 2022
EXPIRATION DATE: April 08, 2023

Learn More & View Event »

Putting Novel Antibody Therapies for COVID-19 in Clinical Context: Evaluating Clinical Data, Monitoring, Infusion Best Practices, and Pediatric EUAs
When Should You Use Monoclonal Antibodies in Pediatric Patients?

COVID-19 FRONTLINE podcasts provide an up-to-date perspective on the use of monoclonal antibodies for the treatment and prevention of COVID-19. Each podcast focuses on different issues facing clinicians, such as identifying candidates for monoclonal antibody therapy, improving access to therapies, incorporating best practices into clinical care, and other important topics.

In this episode, a pediatric infectious disease specialist will clarify when to use monoclonal antibodies in pediatric patients with COVID-19 and discuss ways to overcome challenges in administering therapy.

RELEASE DATE: April 11, 2022
EXPIRATION DATE: April 11, 2023

Learn More & View Event »

New Strategies for Reducing Cardiovascular Risk in CKD with T2D: Development of Finer Mineralocorticoid Antagonists

In this comprehensive and interactive CME activity, we will be presenting important topics in the area of diabetic kidney disease. The program includes slide-based material interspersed with interactive questions and case studies to enhance learning. The focus is on kidney disease in the diabetic patient, specifically mechanisms of disease, diagnosis and evaluation, and therapeutic options.


RELEASE DATE: April 13, 2022
EXPIRATION DATE: April 13, 2023

Learn More & View Event »

Moderate-to-Severe Atopic Dermatitis: Addressing Healthcare Disparities in Urban Communities

This enduring virtual activity targets healthcare gaps related to the treatment and management of AD in urban communities, impacting outcomes through identifying determinants that impact health in urban communities, implementing strategies in disease severity assessment across varying skin tones, and guideline-based care.

RELEASE DATE: April 13, 2022
EXPIRATION DATE: April 13, 2023

Learn More & View Event »

Worldwide Strategies for the Management of BCC and cSCC: Can Immunotherapies Provide Effective Treatment for Your Patients with Non-Melanoma Skin Cancers?

This interactive global educational activity is designed to help oncologists, pathologists, surgeons, dermatologists, and other healthcare practitioners who care for patients with advanced or metastatic basal cell carcinoma (BCC) or cutaneous squamous cell carcinoma (cSCC) to improve their knowledge of the disease, best practices for treatment, and the role of immunotherapy in managing non-melanoma skin cancer (NMSC).

RELEASE DATE: April 18, 2022
EXPIRATION DATE: April 18, 2023

Learn More & View Event »

Clinical and Managed Care Considerations in Chronic Rhinosinusitis With Nasal Polyps (CRSwNP): Considerations in Addressing Underlying Inflammation

In this program; we will aim to discuss the cost burden and pathophysiology of CRSwNP, review guidelines for diagnosis and short- and long-term management, look at clinical data and biomarkers on current and novel anti-inflammatory biologics, and teach pharmacists how to apply best practices within the framework of interdisciplinary managed care of these patients. We will use a combination of didactic lecture, video animations, and patient cases to effectively teach pharmacists who see this condition.

RELEASE DATE: April 18, 2022
EXPIRATION DATE: April 18, 2023

Learn More & View Event »

Evaluating Treatment Selections for Chronic Spontaneous Urticaria: Managed Care Considerations

This enduring MedGames is an interactive gamification-style CME activity that covers important topics in chronic spontaneous urticaria (CSU). The educational format of this program is engaging and covers the economic and physiological burden of CSU, diagnostic algorithms, guideline recommended step-care management, and efficacy and safety of current and emerging biologic therapy.

RELEASE DATE: April 20, 2022
EXPIRATION DATE: April 20, 2023

Learn More & View Event »

Project ECHO: HR+/HER2- Metastatic Breast Cancer: What Can You Do to Optimize Patient Access to Cyclin-dependent Kinase 4 and 6 Inhibitors? – An Innovative View

This enduring TeleECHO educational series targets healthcare gaps related to the familiarity and understanding of CDK4/6 inhibitor clinical trial designs and results on efficacy, safety, and real-world studies, impacting outcomes through current practice patterns and treatment strategies in the management of HR+/HER2- metastatic breast cancer (mBC).

RELEASE DATE: May 04, 2022
EXPIRATION DATE: May 04, 2023

Learn More & View Event »

Putting Novel Antibody Therapies for COVID-19 in Clinical Context: Evaluating Clinical Data, Monitoring, Infusion Best Practices, and Pediatric EUAs

COVID-19 FRONTLINE podcasts provide an up-to-date perspective on the use of monoclonal antibodies for the treatment and prevention of COVID-19. Each podcast focuses on different issues facing clinicians, such as identifying candidates for monoclonal antibody therapy, improving access to therapies, incorporating best practices into clinical care, and other important topics.

In this episode, an emergency medicine physician will discuss strategies for the administration of monoclonal antibodies in adult and pediatric patients in an emergency department setting.

RELEASE DATE: April 29, 2022
EXPIRATION DATE: April 29, 2023

Learn More & View Event »

A Nurses’ Perspective: Oral Therapies in Breast Cancer: Considerations for Enhanced Adherence in the Hormone Receptor-positive/Human Epidermal Growth Factor Receptor 2-negative Breast Cancer

Oncology nurses are in an inherently valuable position to be in the frontline of breast cancer treatment for patients. Given identified gaps and faculty feedback, the instructional design of this program is a multi-pronged educational approach designed for an oncology nursing audience. 

RELEASE DATE: April 29, 2022
EXPIRATION DATE: April 29, 2023

Learn More & View Event »

Psoriatic Arthritis Management: Application of Guidelines and Clinical Evidence for Better Results and Safety

This educational activity will assess the pathophysiology and disease domains of psoriatic arthritis as well as review FDA-approved agents and their roles in in treating the disease. Additionally, we will discuss the appropriateness of combination or monotherapy regimens and unanswered questions in this area.

RELEASE DATE: April 29, 2022
EXPIRATION DATE: April 29, 2023

Learn More & View Event »

Incorporating Clinical Trials Data into the Management of DR, AMD, RVO, mCNV, and PCV

This enduring activity targets healthcare gaps related to the early intervention of retinal vascular diseases and familiarity with new and emerging clinical trial data, impacting outcomes through assessment and synthesis of clinical trial structures, and outcomes of studied anti-VEGF agents for incorporation into treatment strategy development.

RELEASE DATE: April 29, 2022
EXPIRATION DATE: April 29, 2023

Learn More & View Event »

The RELIEF Initiative: Reducing the Burden of Axial Spondyloarthritis Through Screening and Referral

This live virtual activity will help clinicians reduce the significant delay between onset of symptoms and diagnosis of axial spondyloarthritis (axSpA) by identifying patients with inflammatory back pain who should be promptly referred to a rheumatologist for further assessment. Case studies and engaging whiteboard animations on the features of axSpA and the consequences of delays in diagnosis create a memorable and practical learning experience.

RELEASE DATE: April 29, 2022
EXPIRATION DATE: April 29, 2023

Learn More & View Event »

The RELIEF Initiative: Reducing the Burden of Axial Spondyloarthritis Through Screening and Referral

This enduring activity will help clinicians reduce the significant delay between onset of symptoms and diagnosis of axial spondyloarthritis (axSpA) by identifying patients with inflammatory back pain who should be promptly referred to a rheumatologist for further assessment. Case studies and engaging whiteboard animations on the features of axSpA and the consequences of delays in diagnosis create a memorable and practical learning experience.

RELEASE DATE: April 29, 2022
EXPIRATION DATE: April 29, 2023

Learn More & View Event »

Checkpoint Inhibitors for Advanced Non-small Cell Lung Cancer: Understanding Current First-line Strategies

This activity provides a practice-based learning experience for medical oncologists, pulmonologists, nurse practitioners, and other health care providers, regarding the assessment and treatment of non-small cell lung cancer (NSCLC) in the first-line setting. By participating in this Simulation Center, learners will observe an interaction between a patient with NSCLC and their healthcare provider, and will test their knowledge of diagnosis and management at key decision points along the way.

RELEASE DATE: April 29, 2022
EXPIRATION DATE: April 29, 2023

Learn More & View Event »

Clearing the Air on Modern Pneumococcal Vaccination Strategies: Improving Population Outcomes and Simplifying Complex Recommendations in Managed Care

Pneumococcal disease caused by Streptococcus pneumoniae is the leading cause of pneumonia-related deaths and poses an important global public health concern. There are several vaccines available for prevention of this disease, but their implementation in the clinic is challenged by complex recommendations of their administration for various patient populations and by complicated guidelines for appropriate spacing and sequencing of vaccine schedules. Managed Care Specialists need to understand the nuances of pneumococcal vaccines to guide physicians on their appropriate use to reduce infections and improve clinical outcomes, particularly for at-risk patients. This educational activity will explore the impact of pneumococcal disease, pathophysiology of disease, guidelines recommendations, and strategies for managing vaccine hesitancy. In addition to a didactic presentation, the program features animations and case discussions to highlight the different aspects of this disease.

RELEASE DATE: May 10, 2022
EXPIRATION DATE: May 10, 2023

Learn More & View Event »

Novel Mechanisms and Emerging Agents for Anemia of CKD: Best Practices for Evidence-Based Care Across Specialties

This online activity with an integrated case-based learning component will enable clinicians to recognize emerging targets in the management of anemia of chronic kidney disease (CKD) through an understanding of the underlying pathophysiology and clinical trials evaluating novel therapies. By integrating these data with the current standards of care in the management of anemia of CKD, clinicians will be better able to understand the role of multiple healthcare professionals in the management of this common complication of CKD. Additionally, the integrated case-based activity within this program will ensure that healthcare professionals can readily translate learnings to patient interactions, ensuring that patients and the healthcare team are aware fully aware of emerging therapeutic alternatives.

RELEASE DATE: May 13, 2022
EXPIRATION DATE: May 13, 2023

Learn More & View Event »

Preventing Structural Damage in Psoriatic Arthritis: A New Domain

Through a series of informative lectures and podcast interviews, this educational series will target clinicians in the field of rheumatology who have patients with psoriatic arthritis. We will provide the latest information on clinical presentation, differential diagnosis, therapeutic targets, and clinical trial data on current and emerging therapies to help learners reduce both short- and long-term consequences of the disease.

RELEASE DATE: May 13, 2022
EXPIRATION DATE: May 13, 2023

Learn More & View Event »

Considerations in the Evaluation of Real-World Evidence for Patients with Multiple Myeloma: Efficacy and Safety Considerations to Inform Therapy

This enduring TeleECHO program will explore the role of real-world evidence in informing management decisions of elderly and frail patients with relapsed and refractory multiple myeloma (RRMM). A brief didactic presentation will discuss prognostic features and key management considerations for the elderly and frail patient populations. A summary of clinical trial data and real world evidence to inform treatment selection in the first-line and relapse settings will also be presented. Interactive case studies will illustrate strategies for patient counseling and treatment selection in elderly and frail patients with RRMM.

RELEASE DATE: May 20, 2022
EXPIRATION DATE: May 20, 2023

Learn More & View Event »

The Challenges Presented by Hypertrophic Cardiomyopathy in Clinical Practice: How Does Your Approach Compare with the Experts’?

This interactive online activity will explore the diagnosis and management of hypertrophic cardiomyopathy (HCM). A didactic presentation by expert faculty will review guideline recommendations and risk factors for complications, discuss pharmacologic and surgical treatment options, and examine clinical trial data on emerging agents. An animated case will allow learners to apply what they have learned in a simulated clinical encounter.

RELEASE DATE: May 26, 2022
EXPIRATION DATE: May 26, 2023

Learn More & View Event »

Insights in Acute Myeloid Leukemia: Optimizing System Level Quality for Our Veterans

This activity will explore the management of patients with of newly diagnosed and relapsed/refractory acute myeloid leukemia (AML). This program will address the role of genetic and molecular markers in treatment selection as well as best practices for treatment of newly diagnosed, and relapsed/refractory, and secondary AML. A summary of approaches to TRAE recognition and mitigation will also be discussed.

RELEASE DATE: May 26, 2022
EXPIRATION DATE: May 26, 2023

Learn More & View Event »

The Evolution of Incretin Therapy: The Potential Role of GIP/GLP-1 Receptor Agonists in Treating Patients with Obesity and T2DM

This CME program has been designed for endocrinologists who treat patients with type 2 diabetes. It aims to help learners evaluate the impact of weight loss and timely treatment intensification in patients with T2DM on glycemic and metabolic outcomes, and to increase knowledge of the mechanism of emerging GIP/GLP-1 receptor agonists and their impact on glycemic outcomes and body weight in order to advantageously integrate them into clinical practice when available.

RELEASE DATE: May 31, 2022
EXPIRATION DATE: May 31, 2023

Learn More & View Event »

Why Weight? Obesity Management as a Treatment Goal for Patients with Type 2 Diabetes

This CME program has been designed to provide participants with the knowledge necessary to simultaneously address weight management and glycemic control in patients with type 2 diabetes and obesity/overweight. Participants will gain a greater understanding of guidelines-recommended pharmaceutical and lifestyle management strategies, and learn how incretin therapies with beneficial impacts on glycemic outcomes and body weight can be integrated into clinical practice. In addition to viewing a faculty presentation of relevant clinical data and guidelines, learners will participate in Med Games, an engaging gamified learning activity featuring interactive quizzes and video case studies that provide the opportunity to make decisions about patient care and get immediate feedback.

RELEASE DATE: May 31, 2022
EXPIRATION DATE: May 31, 2023

Learn More & View Event »

PARP Inhibitor–based Combinations for the Management of Patients with Metastatic Castration-resistant Prostate Cancer: What Are the Data Telling Us?

This enduring activity has been designed for HCPs treating metastatic castration-resistant prostate cancer (mCRPC) to improve: knowledge of the mechanisms of action of PARP inhibitor–based combinations for the treatment of patients with mCRPC with or without DNA damage response (DDR) alterations; awareness of new clinical data on the efficacy, safety, and tolerability of emerging PARP inhibitor–based combinations with different mechanisms of action for the treatment of patients with mCRPC; and their ability to develop individualized management plans for patients with mCRPC with or without DDR alterations that include PARP inhibitor–based combinations if appropriate.

RELEASE DATE: May 31, 2022
EXPIRATION DATE: May 31, 2023

Learn More & View Event »

Reducing the Burden and Cost of Chronic Spontaneous Urticaria

This enduring MedGames is an interactive gamification-style CME activity that covers important topics in chronic spontaneous urticaria (CSU). The educational format of this program is engaging and covers the economic and physiological burden of CSU, diagnostic algorithms, guideline-recommended step-care management, and efficacy and safety of current and emerging biologic therapy.

RELEASE DATE: May 31, 2022
EXPIRATION DATE: May 31, 2023

Learn More & View Event »

Treating COVID-19 Based on Disease Severity: Key Considerations in Hospitalized Patients

In this educational activity, expert faculty will discuss the use of approved and authorized treatments for the management of patients hospitalized with COVID-19. A review of clinical trial data on the efficacy and safety of therapeutic options and strategies for selecting therapy based on disease severity and clinical factors will allow clinicians to reduce the need for invasive ventilation and improve patient outcomes.

RELEASE DATE: May 31, 2022
EXPIRATION DATE: May 31, 2023

Learn More & View Event »

Putting Novel Antibody Therapies for COVID-19 in Clinical Context: Evaluating Clinical Data, Monitoring, Infusion Best Practices, and Pediatric EUAs

COVID-19 FRONTLINE podcasts provide an up-to-date perspective on the use of monoclonal antibodies for the treatment and prevention of COVID-19. Each podcast focuses on different issues facing clinicians, such as identifying candidates for monoclonal antibody therapy, improving access to therapies, incorporating best practices into clinical care, and other important topics.

RELEASE DATE: June 01, 2022
EXPIRATION DATE: June 01, 2023

Learn More & View Event »

Nontuberculous Mycobacterial Lung Disease (NTM-LD): Overcoming Common Pitfalls in Diagnosis and Treatment

This enduring activity will explore the diagnosis and management of NTM-LD. Whiteboard animations will identify common pitfalls that lead to delays in diagnosis and look at the mechanism of action of novel therapies for refractory disease. A case-based didactic lecture led by expert faculty will review guideline-recommended care, strategies to minimize adverse events, and clinical trial data on newer treatment options.

RELEASE DATE: June 01, 2022
EXPIRATION DATE: June 01, 2023

Learn More & View Event »

Improving Outcomes in Pediatric and Adult Patients with Eosinophilic Esophagitis Through Earlier Diagnosis and Treatment

This case-based enduring activity will focus on the epidemiology, pathophysiology, diagnosis, and treatment of eosinophilic esophagitis (EoE). Patients with EoE are often diagnosed after symptom onset, leading to greater chronic inflammation, and treatment plans are frequently not tailored to individual needs. This activity is intended to help healthcare professionals diagnose EoE earlier and provide individualized treatment based on guidelines, recent clinical data and patient characteristics.

RELEASE DATE: June 03, 2022
EXPIRATION DATE: June 03, 2023

Learn More & View Event »

Treating COVID-19 Based on Disease Severity: Key Considerations in Hospitalized Patients

This educational activity will review clinical trial data on the use of authorized therapies for the management of patients hospitalized with COVID-19 and explore strategies to incorporate these therapeutic options into clinical practice. This program includes a whiteboard animation on the role of inflammation in the pathophysiology of severe COVID-19 and the mechanism of action of available treatment options.

RELEASE DATE: June 07, 2022
EXPIRATION DATE: June 07, 2023

Learn More & View Event »

A Patient-Centered Approach to Concussion Care for Emergency Medicine and Primary Care Physicians

This online activity has been designed for primary care, emergency care, sports neurologists, headache neurologists, and other healthcare professionals involved in the management of people with acute and chronic post-concussion symptoms to help them in evaluating and treating patients by using a patient-centered approach. This activity includes a personal interview featuring a patient who has experienced concussion and is now living with post-concussion syndrome.

RELEASE DATE: June 13, 2022
EXPIRATION DATE: June 13, 2023

Learn More & View Event »

Modifying Chronic Kidney Disease Risk in Patients With Type 2 Diabetes: Opportunities and Robust Data With Mineralocorticoid Antagonists

This enduring activity is designed to review the importance of chronic kidney disease (CKD) risk reduction in patients with T2D, how to evaluate opportunities to screen for CKD risk in patients with T2D and target reductions in albuminuria, the manageability of hyperkalemia and uniqueness of novel therapy, and key takeaways and practice changes.

RELEASE DATE: June 16, 2022
EXPIRATION DATE: June 16, 2023

Learn More & View Event »

Optimal Management of Patients with Cancer-associated Venous Thromboembolism: The Important Role of Anticoagulation Therapy

This enduring activity will focus on the latest updates in the optimal management of cancer-associated venous thromboembolism (VTE) based on risk stratification, clinical trial data, and appropriate guideline-informed strategies to optimize clinical outcomes. This program will inform participants of the latest best practices as recommended by professional guidelines and will equip participants to integrate multidisciplinary care and shared decision-making in practice.

RELEASE DATE: June 20, 2022
EXPIRATION DATE: June 20, 2023

Learn More & View Event »

Diversity, Equity and Inclusion in Ophthalmology: Health Disparities in Ocular Disease

This enduring activity targets healthcare gaps related to awareness of health disparities in the prevention and treatment of ocular diseases and the importance of diverse representation within clinical trials and the ophthalmology workforce, impacting outcomes through assessing for factors that can contribute to disparities in vision health and strategies to overcome them.

RELEASE DATE: June 24, 2022
EXPIRATION DATE: June 24, 2023

Learn More & View Event »

Putting Novel Antibody Therapies for COVID-19 in Clinical Context: Evaluating Clinical Data, Monitoring, Infusion Best Practices, and Pediatric EUAs

COVID-19 FRONTLINE podcasts provide an up-to-date perspective on the use of monoclonal antibodies for the treatment and prevention of COVID-19. Each podcast focuses on different issues facing clinicians, such as identifying candidates for monoclonal antibody therapy, improving access to therapies, incorporating best practices into clinical care, and other important topics.

In this episode, an emergency nurse will review how to administer monoclonal antibodies in patients with COVID-19 and best practices for monitoring for adverse reactions.

RELEASE DATE: June 27, 2022
EXPIRATION DATE: June 27, 2023

Learn More & View Event »

A Closer Look at Evolving Treatment Strategies in Rheumatology: Exploring Best Practices for the Timely Diagnosis and Management of RA, PsA, AxSpA and JIA

This educational activity will explore best practices for the management of rheumatoid arthritis (RA), axial spondyloarthritis (axSpA) and psoriatic arthritis (PsA) and juvenile idiopathic arthritis (JIA). Expert faculty will review the latest information on clinical presentation, treatment recommendations, and clinical trial data on available therapies to help learners reduce both short- and long-term consequences of disease. An innovative simulation center will allow clinicians to apply what they have learned in an interactive, animated case.

RELEASE DATE: June 27, 2022
EXPIRATION DATE: June 27, 2023

Learn More & View Event »

Applying Evidence-Based Therapy Through Oncology Nursing That Maximizes HER2-Targeted Efficacy While Enhancing Tolerability

Oncology nurses are in an inherently valuable position to be in the frontline for treatment of HER2-positive solid tumors. Given identified gaps and faculty feedback, the instructional design of this program is a multi-pronged educational approach designed for an oncology nursing audience. For additional resources, please visit www.oncologynurse-ce.com.

RELEASE DATE: June 29, 2022
EXPIRATION DATE: June 29, 2023

Learn More & View Event »

Optimizing Patient Outcomes in Gaucher Disease:
Evaluating the Latest Enzyme Replacement Therapies

This online activity is designed to increase HCPs recognition of metabolic pathways involved in the pathophysiology of Gaucher disease; confidence discussing clinical trial data supporting improved outcomes in Gaucher disease; understanding of the potential for treatment to modify outcomes in Gaucher disease; and understanding of shared decision-making best practices for long-term management of Gaucher disease.

RELEASE DATE: May 26, 2022
EXPIRATION DATE: May 26, 2023

Learn More & View Event »

Advances in Atopic Dermatitis: The Emerging Role of JAK Inhibitors for Moderate-to-Severe Disease

This enduring activity has been designed to help dermatologists, pediatric dermatologists, primary care physicians, advanced practice providers (NPs and PAs) and other healthcare providers who are involved in the care and treatment of patients with atopic dermatitis to assess patients for physical and psychosocial burdens of AD; identify candidates for systemic therapies; better evaluate recent clinical trial data on the efficacy and safety of JAK inhibitors for the management of moderate-to-severe AD; and apply evidence-based approaches to manage moderate-to-severe AD and monitor for adverse events.

RELEASE DATE: July 12, 2022
EXPIRATION DATE: July 12, 2023

Learn More & View Event »

Approaches to Improving Care in Chronic Lymphocytic Leukemia in the Veteran’s Affairs System: Insights from the Experts

This activity will explore the management of patients with of treatment-naïve and relapsed/refractory chronic lymphocytic leukemia (CLL). This program will address approaches to individualize selection of therapy and the role of minimal residual disease (MRD) in monitoring treatment effectiveness. A summary of approaches to TRAE recognition and mitigation will also be addressed.

RELEASE DATE: July 07, 2022
EXPIRATION DATE: July 07, 2023

Learn More & View Event »

Using Targeted Treatment Options for the Management of BRAF-mutant Metastatic Colorectal Cancer: How Does Your Approach Compare with the Experts?

This podcast will explore the management of patients with metastatic colorectal cancer (mCRC). Faculty will review strategies on personalizing the selection of treatment options based on molecular testing; and discuss the management of adverse events with targeted treatments for BRAF V600-mutant mCRC.

RELEASE DATE: July 08, 2022
EXPIRATION DATE: July 08, 2023

Learn More & View Event »

Current Perspectives on the Recognition and Prevention of Dengue Fever Worldwide: Novel Opportunities to Reduce Burden of Disease in 2022

This activity discusses the growing impact of dengue fever worldwide and strategies to mitigate its spread. Featured topics of this program include signs and symptoms of dengue fever and differential diagnoses, the lifecycle of a dengue infection, and clinical trial data of approved and emerging vaccines.

RELEASE DATE: July 18, 2022
EXPIRATION DATE: July 18, 2023

Learn More & View Event »

Putting Novel Antibody Therapies for COVID-19 in Clinical Context: Evaluating Clinical Data, Monitoring, Infusion Best Practices, and Pediatric EUAs

COVID-19 FRONTLINE podcasts provide an up-to-date perspective on the use of monoclonal antibodies for the treatment and prevention of COVID-19. Each podcast focuses on different issues facing clinicians, such as identifying candidates for monoclonal antibody therapy, improving access to therapies, incorporating best practices into clinical care, and other important topics.

RELEASE DATE: July 19, 2022
EXPIRATION DATE: July 19, 2023

Learn More & View Event »

Novel Therapeutic Perspectives in the Management of DLBCL: The Role of Antibody-Drug Conjugates and Bispecific Antibodies

This Community Whiteboard ECHO Series and Online Enduring activity is designed to increase the multi-disciplinary oncology care team recognition of the role of targeted and bispecific antibodies in management of relapsed/refractory DLBCL; strengthen their understanding of clinical trial outcomes and adverse events with targeted and bispecific antibodies; and improve their awareness of multidisciplinary best practices for managing adverse events from targeted therapies.

RELEASE DATE: July 20, 2022
EXPIRATION DATE: July 20, 2023

Learn More & View Event »

Addressing Treatment Fatigue: Long-Acting Growth Hormone for the Pediatric Patient with GH Deficiency

This activity features education regarding hormone therapy for children and adolescents with growth hormone (GH) deficiency. The program will discuss the diagnosis of GH deficiency, challenges of currently available therapies, clinical data of emerging therapies, and strategies to personalize care for childhood growth hormone deficiency (CGHD).

RELEASE DATE: July 22, 2022
EXPIRATION DATE: July 22, 2023

Learn More & View Event »

Emphasizing the Diabetes Care Team in the Diagnosis and Management of Diabetic Retinopathy

This online program targets critical issues in diabetic retinopathy, including the importance of screening and early detection of retinopathy, how early treatment in retinopathy can help prevent progression to vision-threatening complications, and the advantageous impact of multidisciplinary management in the care of a retinopathy patient. Learn essential elements of screening, referral, and treatment, as well as core systemic factors affecting risk for both development and worsening of diabetic eye disease, which when optimized can help preserve vision in diabetes.

RELEASE DATE: July 27, 2022
EXPIRATION DATE: July 27, 2023

Learn More & View Event »

Beyond Conventional Anti-VEGF Therapy:
Reducing the Burden of Treatment and Improving Outcomes in Diabetic Macular Edema and Neovascular Age-Related Macular Degeneration

This case-based online activity is designed for retina specialists, ophthalmologists, primary care providers, optometrists, and other healthcare providers who manage patients with neovascular age-related macular degeneration and/or diabetic macular edema. The activity aims to improve treatment for patients who do not achieve optimal outcomes due to insufficient responses to therapy or insufficient adherence. In addition, it will elucidate the benefits and limitations of current therapeutic approaches, equip participants with strategies for improving the durability of treatment response in patients receiving intravitreal therapies, and provide education on new and emerging treatment strategies.

RELEASE DATE: July 28, 2022
EXPIRATION DATE: July 28, 2023

Learn More & View Event »

Beyond Conventional Anti-VEGF Therapy:
Reducing the Burden of Treatment and Improving Outcomes in Diabetic Macular Edema and Neovascular Age-Related Macular Degeneration

PODCAST ACTIVITY: These podcasts provide an up-to-date perspective on improving treatment for patients with neovascular age-related macular degeneration and/or diabetic macular edema who do not achieve optimal outcomes due to insufficient responses to therapy or insufficient adherence. This series of podcasts will elucidate the benefits and limitations of current therapeutic approaches for patients with nAMD or DME, equip participants with strategies for improving the durability of treatment response in patients receiving intravitreal therapies, and provide education on new and emerging treatment strategies.

RELEASE DATE: July 28, 2022
EXPIRATION DATE: July 28, 2023

Learn More & View Event »

A New Day in Type 2 Diabetes in Chronic Kidney Disease: Addressing Risks and Disparities of Care to Optimize Nephrology Care in 2022 — A Nephrology Fellows Program

This educational opportunity has been designed for nephrology fellows to ensure recognition of CKD risk in patients with T2D, understand novel strategies for modifying CKD risk, and review the risk of other chronic complications of T2D. We aim to evaluate current strategies for the management of CKD in T2D using novel therapeutic agents that modify long-term clinical outcomes, including third-generation mineralocorticoid antagonists; describe current disparities in CKD care in T2D and strategies for integrating novel strategies in practice, including third-generation mineralocorticoid antagonists; and lastly to summarize safety data with novel agents in the management of CKD in T2D, including best practices for managing hyperkalemia with novel mineralocorticoid antagonists.

RELEASE DATE: July 28, 2022
EXPIRATION DATE: July 28, 2023

Learn More & View Event »

Insights to Improve Responses to Immunotherapies: A Simulation Center Approach to Identifying Patients Who May Benefit from Predictive Biomarkers

This simulated activity depicts conversations between an oncologist, a pathologist, and a patient diagnosed with non-small cell lung cancer (NSCLC). You will watch as they engage with each other throughout the various stages of a patient’s journey, from the initial pathologic and oncologic workup at initial presentation to disease recurrence. You will participate in the simulation by answering questions throughout the activity. A brief slide presentations is available within each simulation center activity to enhance your understanding of immunological biomarkers.

RELEASE DATE: August 04, 2022
EXPIRATION DATE: August 04, 2023

Learn More & View Event »

Clinical Pearls for Community-based Oncologists Treating Patients with BRAF-mutated Metastatic Melanoma: Incorporating Novel Sequencing Strategies into Practice

This enduring TeleECHO program will explore key clinical practice insights for management of patients with BRAF-mutated metastatic melanoma. Over the course of this activity there will be discussion of the clinical profiles of frontline combination immuno- and targeted treatment options in BRAF-mutated metastatic melanoma as well as emerging data from clinical trials and real-world studies examining sequencing of these therapies. Interactive case studies will illustrate strategies for treatment selection, mitigation of adverse events, and management considerations for patients with BRAF-mutated metastatic melanoma.

RELEASE DATE: August 11, 2022

EXPIRATION DATE: August 11, 2023

Learn More & View Event »
Scroll to Top

A Special Thank You to All HCPs

Med Learning Group sends its heartful gratitude to all healthcare professionals giving their all, 24/7, during this pandemic, despite the great risks they face. We cannot thank you enough for your courage and selfless service.

Connecting you with our personalized approach to continuing Medical Education

The Linking Approach to Education from Gap Analysis to Outcomes

Med Learning Group, a division of Ultimate Medical Academy, is a full-service accredited medical education company with commendation. Med Learning Group focuses on developing and implementing continuing education that improves healthcare practitioners’ ability to provide optimal care to their patients. Our goal is to provide high-quality education that is designed to deliver the highest level of outcomes for not only the practitioner, but also the patient. Med Learning Group has expertise in developing both live and online activities that are innovative, case-based, interactive and patient-centric in nature.

Med Learning Group has expertise in developing both live and online activities that are innovative, case-based, interactive and patient-centric in nature, and we focus on applying adult learning theory and principles to our programs. Even more importantly, we understand the nuances of our target audiences and design programs with a grounded understanding of how to educate both specialty audiences and general practitioners.